Back to Search
Start Over
Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage III/IV melanoma: A randomized, double-blind, phase 3 trial (CheckMate 238)
- Source :
- Publons
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
- Subjects :
- Oncology
medicine.medical_specialty
business.industry
Melanoma
Checkmate
Ipilimumab
Hematology
030204 cardiovascular system & hematology
medicine.disease
Complete resection
Double blind
03 medical and health sciences
0302 clinical medicine
Internal medicine
Adjuvant therapy
Medicine
Stage (cooking)
Nivolumab
business
030217 neurology & neurosurgery
medicine.drug
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 28
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi.dedup.....934855b7c58c754e449c78bc7d6fe3ee